These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 20534345)

  • 41. Selective inhibition of CBP/p300 HAT.
    Sarli V; Giannis A
    Chem Biol; 2007 Jun; 14(6):605-6. PubMed ID: 17584607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure and chemistry of the p300/CBP and Rtt109 histone acetyltransferases: implications for histone acetyltransferase evolution and function.
    Wang L; Tang Y; Cole PA; Marmorstein R
    Curr Opin Struct Biol; 2008 Dec; 18(6):741-7. PubMed ID: 18845255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of the acetyltransferases p300 and CBP reveals a targetable function for p300 in the survival and invasion pathways of prostate cancer cell lines.
    Santer FR; Höschele PP; Oh SJ; Erb HH; Bouchal J; Cavarretta IT; Parson W; Meyers DJ; Cole PA; Culig Z
    Mol Cancer Ther; 2011 Sep; 10(9):1644-55. PubMed ID: 21709130
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discovery of berberine analogs as potent and highly selective p300/CBP HAT inhibitors.
    Zhong X; Deng H; Long M; Yin H; Zhong Q; Zheng S; Gong T; He L; Wang G; Sun Q
    Bioorg Chem; 2023 Sep; 138():106597. PubMed ID: 37245245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome.
    Weinert BT; Narita T; Satpathy S; Srinivasan B; Hansen BK; Schölz C; Hamilton WB; Zucconi BE; Wang WW; Liu WR; Brickman JM; Kesicki EA; Lai A; Bromberg KD; Cole PA; Choudhary C
    Cell; 2018 Jun; 174(1):231-244.e12. PubMed ID: 29804834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of the CBP catalytic core in intramolecular SUMOylation and control of histone H3 acetylation.
    Park S; Stanfield RL; Martinez-Yamout MA; Dyson HJ; Wilson IA; Wright PE
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):E5335-E5342. PubMed ID: 28630323
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Histone acetyl transferases as emerging drug targets.
    Dekker FJ; Haisma HJ
    Drug Discov Today; 2009 Oct; 14(19-20):942-8. PubMed ID: 19577000
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-histone acetyltransferase activity from allspice extracts inhibits androgen receptor-dependent prostate cancer cell growth.
    Lee YH; Hong SW; Jun W; Cho HY; Kim HC; Jung MG; Wong J; Kim HI; Kim CH; Yoon HG
    Biosci Biotechnol Biochem; 2007 Nov; 71(11):2712-9. PubMed ID: 17986787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
    Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of lysine acetyltransferase KAT3B/p300 activity by a naturally occurring hydroxynaphthoquinone, plumbagin.
    Ravindra KC; Selvi BR; Arif M; Reddy BA; Thanuja GR; Agrawal S; Pradhan SK; Nagashayana N; Dasgupta D; Kundu TK
    J Biol Chem; 2009 Sep; 284(36):24453-64. PubMed ID: 19570987
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases.
    Mai A; Rotili D; Tarantino D; Nebbioso A; Castellano S; Sbardella G; Tini M; Altucci L
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1132-5. PubMed ID: 19144517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiple roles for acetylation in the interaction of p300 HAT with ATF-2.
    Karanam B; Wang L; Wang D; Liu X; Marmorstein R; Cotter R; Cole PA
    Biochemistry; 2007 Jul; 46(28):8207-16. PubMed ID: 17590016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of p300/CBP Acetylation of Nucleosomes by Bromodomain Ligand I-CBP112.
    Zucconi BE; Luef B; Xu W; Henry RA; Nodelman IM; Bowman GD; Andrews AJ; Cole PA
    Biochemistry; 2016 Jul; 55(27):3727-34. PubMed ID: 27332697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting p300 Addiction in CBP-Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of MYC Expression.
    Ogiwara H; Sasaki M; Mitachi T; Oike T; Higuchi S; Tominaga Y; Kohno T
    Cancer Discov; 2016 Apr; 6(4):430-45. PubMed ID: 26603525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dissociable roles for histone acetyltransferases p300 and PCAF in hippocampus and perirhinal cortex-mediated object memory.
    Mitchnick KA; Creighton SD; Cloke JM; Wolter M; Zaika O; Christen B; Van Tiggelen M; Kalisch BE; Winters BD
    Genes Brain Behav; 2016 Jul; 15(6):542-57. PubMed ID: 27251651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acetyltransferases CBP/p300 Control Transcriptional Switch of β-Catenin and Stat1 Promoting Osteoblast Differentiation.
    Zhang L; Zhu K; Xu J; Chen X; Sheng C; Zhang D; Yang Y; Sun L; Zhao H; Wang X; Tao B; Zhou L; Liu J
    J Bone Miner Res; 2023 Dec; 38(12):1885-1899. PubMed ID: 37850815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Small molecule modulators of histone acetyltransferase p300.
    Balasubramanyam K; Swaminathan V; Ranganathan A; Kundu TK
    J Biol Chem; 2003 May; 278(21):19134-40. PubMed ID: 12624111
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeted degradation of the enhancer lysine acetyltransferases CBP and p300.
    Vannam R; Sayilgan J; Ojeda S; Karakyriakou B; Hu E; Kreuzer J; Morris R; Herrera Lopez XI; Rai S; Haas W; Lawrence M; Ott CJ
    Cell Chem Biol; 2021 Apr; 28(4):503-514.e12. PubMed ID: 33400925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human T-cell leukemia virus type-1-encoded protein HBZ represses p53 function by inhibiting the acetyltransferase activity of p300/CBP and HBO1.
    Wright DG; Marchal C; Hoang K; Ankney JA; Nguyen ST; Rushing AW; Polakowski N; Miotto B; Lemasson I
    Oncotarget; 2016 Jan; 7(2):1687-706. PubMed ID: 26625199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. C646, a Novel p300/CREB-Binding Protein-Specific Inhibitor of Histone Acetyltransferase, Attenuates Influenza A Virus Infection.
    Zhao D; Fukuyama S; Sakai-Tagawa Y; Takashita E; Shoemaker JE; Kawaoka Y
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1902-6. PubMed ID: 26711748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.